Mesenchymal Stem Cells for Prophylaxis of Chronic Graft-vs-Host Disease After Haploidentical Hematopoietic Stem Cell TransplantRuihao Huang, Xi Zhang, Li Gao et al.|JAMA Oncology|2023Cited by 53
Abstract CT052: Clinical safety and efficacy study of TruUCAR™ GC027: The first-in-human, universal CAR-T therapy for adult relapsed/refractory T-cell acute lymphoblastic leukemia (r/r T-ALL)Xinxin Wang, Xi Zhang, Shiqi Li et al.|Cancer Research|2020Cited by 30
Efficacy and toxicity of <scp>CLAG</scp> combined with pegylated liposomal doxorubicin in the treatment of refractory or relapsed acute myeloid leukemiaHan Yao, Xi Zhang, Cheng Zhang et al.|Cancer Medicine|2023Cited by 10
Donor-derived CD19 CAR-T Cells versus Chemotherapy Plus Donor Lymphocyte Infusion for Treatment of Recurrent CD19-positive B-ALL After Allogeneic Hematopoietic Stem Cell TransplantationXu Tan, Shifeng Lou, Xiaoqi Wang et al.|Current Medical Science|2023Cited by 8
A Prospective, Multi-Center, Randomized, Controlled Clinical Trial to Explore the Role of Mesenchymal Stem Cells in Preventing Graft Versus Host DiseaseHan Yao, Xi Zhang, Xiaoqi Wang et al.|Blood|2023Cited by 1